Loss of antibodies, but not of protection.

@article{Wenzel2010LossOA,
  title={Loss of antibodies, but not of protection.},
  author={J. Wenzel and W. Jilg},
  journal={The Lancet. Infectious diseases},
  year={2010},
  volume={10 11},
  pages={
          738-9
        }
}
In The Lancet Infectious Diseases today, Zanetti and colleagues report fi ndings about the duration of immunity against hepatitis B in children vaccinated with either of two hexavalent vaccines—hexavac or infanrix hexa. In 2005, hexavac was suspended by the European Medicines Agency (EMA) because of concerns about long-term protection against hepatitis. Zanetti and colleagues aimed to assess immunity to hepatitis B in children given hexavac and to investigate whether booster injections were… Expand
Lessons learnt over two decades of vaccination against hepatitis B in Italy
Lasting benefit of infant hepatitis B vaccination in adolescents in the Lao People's Democratic Republic.
The effects of booster vaccination of hepatitis B vaccine on children 5–15 years after primary immunization: A 5-year follow-up study
Determinants of Long-term Protection After Hepatitis B Vaccination in Infancy: A Meta-analysis
...
1
2
...

References

SHOWING 1-10 OF 11 REFERENCES
...
1
2
...